Delivery Order SPE2DB22D3009-SPE2DB25FBB51
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,178.96 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) under a firm fixed price contract with a completion date of July 22, 2025. This non-set-aside award was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's larger federal pharmaceutical supply arrangement with DLA....
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,493.78 contract is for the delivery of the drug Xcopri 50 mg tablets to support military healthcare programs. The contract has an ultimate completion date of March 6, 2025. This delivery order is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award, valued at $1,002.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product Xcopri 50 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation. The firm fixed price order, valued at approximately $2,165, supports the delivery of 100mg Xcopri tablets to a Defense Department facility in Conshohocken, Pennsylvania. Performance will be completed by August 23, 2023. As a leading provider of pharmaceuticals and healthcare solutions to the U.S. military and other federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, for the delivery of Xcopri 50 mg tablets. The award, valued at $2,966.87, is a firm fixed price delivery order with an ultimate completion date of April 11, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xcopri 50 mg tablets, with a ceiling value of $1,987.50 and a period of performance through June 6, 2025. The contract is a firm-fixed-price delivery order and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription medication Xcopri (cenobamate) 50 mg tablets. The contract has a ceiling value of $4,903.86 and a period of performance through April 21, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.96 delivery order contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance ending on June 12, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,528.78 firm fixed-price delivery order is for XCOPRI 100 MG TABLET 30S, a prescription medication. The contract has a completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide...